investment decisions

value of evidence

The value of the evidence base plays a crucial part in any investment decision but it can be difficult to assess the real quality of what is available. Translucency has enormous experience in evaluating clinical and other product evidence and we are able to compare what is available against the requirements of a wide range of decision-makers. We can put a value for you on the available evidence and advise on any gaps and what it will take to fill these gaps. We have a track record in assessing successfully the likely performance of a product at an early stage in its life cycle.